Clear Search

Books+ Search Results

Subject: "Drug development"
LC Class: Is
Is Is Not
K - Law

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

Show Online Results Only
Online Results (21)
1.
Achieving proof of concept in drug discovery and development the role of competition law in collaborations between public research organizations and industry
Author
Yu, Helen
Published
Northampton, MA : Edward Elgar Pub., c. 2016.
Online
Online Book
Location
Yale Internet Resource
Format
Books / Online
2.
Patently innovative : how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs
Author
Bouchard, Ron A.
Published
Oxford ; New York : Biohealthcare, 2012.
Location
Law Library >> K1519.D78 B68 2012
Format
Books
3.
Patently innovative : how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs
Author
Bouchard, Ron A.
Published
Cambridge, U.K. ; Philadelphia, PA : Woodhead Pub., 2012.
Online
Online book
Location
Yale Internet Resource >> None
Format
Books / Online
4.
Second generation patents in pharmaceutical innovation
Author
Ahn, Hyewon
Published
Baden-Baden : Nomos, 2014.
©2014.
Location
Law Library >> K1519.D78 A746 2014
Format
Books
5.
Strengthening a workforce for innovative regulatory science in therapeutics development workshop summary
Published
Washington, D.C. : National Academies Press, 2012.
Online
Online book
Location
Yale Internet Resource >> None
Format
Books / Online
6.
21st century cures : the President's Council of Advisors on Science and Technology (PCAST) report on drug innovation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, May 20, 2014
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2015.
Online
http://purl.fdlp.gov/GPO/gpo55610
Location
Yale Internet Resource >> None
Format
Books / Online
7.
Auswirkungen des internationalen Patentregimes auf die Medikamentenproduktion und den Zugang zu Medikamenten in LDCs
Author
Liebig, Klaus
Published
Bonn : Deutsches Institut für Entwicklungspolitik, 2006.
Location
Library Shelving Facility (LSF) >> K1519.D78 L54X 2006 (LC)
Format
Books
8.
Unsustainable drug prices : hearing before the Committee on Oversight and Reform, House of Representatives
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2020-2021.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-123
Format
Books
9.
Continuing America's leadership : realizing the promise of precision medicine for patients : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session ... May 5, 2015
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
PDF version:
Text version:
Location
Yale Internet Resource >> None
Format
Books / Online
10.
Continuing America's leadership : realizing the promise of precision medicine for patients : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session, on examining precision medicine for patients, May 5, 2015
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.114-606
Format
Books
11.
21st century cures : incorporating the patient perspective : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, July 11, 2014
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2015.
Online
http://purl.fdlp.gov/GPO/gpo56008
Location
Yale Internet Resource >> None
Format
Books / Online
12.
FDA checkup : drug development and manufacturing challenges : hearing before the Subcommittee on Energy Policy, Health Care and Entitlements of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Thirteenth Congress, first session, December 12, 2013
Author
United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Energy Policy, Health Care, and Entitlements, author
Published
Washington : U.S. Government Printing Office, 2014.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office
Location
Library Shelving Facility (LSF) >> Y 4.G 74/7:113-101
Format
Books
13.
PDUFA V medical innovation, jobs, and patients : hearing before the Subcommittee on Health of the Committee on Commerce, House of Representatives, One Hundred Twelfth Congress, first session, July 7, 2011
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Published
Washington : U.S. G.P.O., 2012.
Online
http://purl.fdlp.gov/GPO/gpo26461
Location
Yale Internet Resource >> None
Format
Books / Online
14.
Pharmaceutical law : regulation of research, development, and marketing
Published
Arlington, Va : Bureau of National Affairs, c2007.
Location
Law Library >> KF2915.P4 P495 2007
Format
Books
15.
Intellectual property and health technologies : balancing innovation and the public's health
Author
Brougher, Joanna T.
Published
New York ; Heidelberg ; Dordrecht ; London : Springer, [2014]
©2014.
Location
Law Library >> KF3894.P3 B76 2014
Format
Books
16.
Examining H.R. 3299, Strengthening Public Health Emergency Response Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, May 19, 2016
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:114-147
Format
Books
17.
Examining H.R. 3299, Strengthening Public Health Emergency Response Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, May 19, 2016
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
PDF version:
Location
Yale Internet Resource >> None
Format
Books / Online
18.
Twenty-first century cures : examining the roles of incentives in advancing treatments and cures for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, June 11, 2014
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Printing Office, 2014.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Printing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:113-151
Format
Books
19.
Biologics and biosimilars : balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2010.
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:111-73
Format
Books
20.
Biologics and biosimilars balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy
Published
Washington : U.S. G.P.O., 2010.
Online
http://purl.access.gpo.gov/GPO/LPS122600
Location
Yale Internet Resource >> None
Format
Books / Online
21.
Unsustainable drug prices : testimony from the CEOs : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2020.
Online
https://purl.fdlp.gov/GPO/gpo149312
Location
Yale Internet Resource >> None
Format
Books / Online
22.
Follow-on biologics hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O., 2008.
Online
Text version:
PDF version:
Location
Yale Internet Resource >> None
Format
Books / Online
23.
Follow-on biologics : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.110-375
Format
Books
24.
Food and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session, special hearing, June 23, 2010, Washington, D.C.
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Published
Washington : U.S. G.P.O., 2011.
Online
http://purl.fdlp.gov/GPO/gpo4112
Location
Yale Internet Resource >> None
Format
Books / Online
25.
Food and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session, special hearing, June 23, 2010, Washington, D.C.
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2011.
Location
Library Shelving Facility (LSF) >> Y 4.AP 6/2:S.HRG.111-841
Format
Books